242 related articles for article (PubMed ID: 32734001)
21. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease.
Givens JR; Andersen RN; Wiser WL; Donelson AJ; Coleman SA
J Clin Endocrinol Metab; 1975 Nov; 41(5):845-53. PubMed ID: 171277
[TBL] [Abstract][Full Text] [Related]
22. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report.
Ravi SJ; Cree-Green M
J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263
[TBL] [Abstract][Full Text] [Related]
23. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Pall M; Azziz R; Beires J; Pignatelli D
Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
[TBL] [Abstract][Full Text] [Related]
24. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
25. Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature.
Wong FCK; Chan AZ; Wong WS; Kwan AHW; Law TSM; Chung JPW; Kwok JSS; Chan AOK
Case Rep Endocrinol; 2019; 2019():9237459. PubMed ID: 31772787
[TBL] [Abstract][Full Text] [Related]
26. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
27. Secondary Amenorrhea and Infertility Due to an Inhibin B Producing Granulosa Cell Tumor of the Ovary. A Rare Case Report and Literature Review.
Gică C; Cigăran RG; Botezatu R; Panaitescu AM; Cimpoca B; Peltecu G; Gică N
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441035
[TBL] [Abstract][Full Text] [Related]
28. An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome.
Ho JH; Abd Wahab AV; Fung YK; Khoo SSK
Endocrinol Diabetes Metab Case Rep; 2021 Feb; 2021():. PubMed ID: 33597313
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
30. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
[TBL] [Abstract][Full Text] [Related]
31. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
Pignatelli D
Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
[TBL] [Abstract][Full Text] [Related]
32. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
[TBL] [Abstract][Full Text] [Related]
33. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
34. A rare granulosa cell tumor presentation with virilization and cystic adnexal mass on three-dimensional ultrasound: a case report.
Tanouye S; Gada R; Famuyide A; Coddington C
J Reprod Med; 2014; 59(7-8):421-4. PubMed ID: 25098035
[TBL] [Abstract][Full Text] [Related]
35. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
[TBL] [Abstract][Full Text] [Related]
36. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
37. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-secreting adrenocortical tumor in a postmenopausal woman: a challenging diagnosis.
Mermejo LM; Carvalho FG; Molina CAF; Tucci S; Muglia VF; Elias J; Elias PCL; Castro M; Moreira AC
Endocrinol Diabetes Metab Case Rep; 2021 Mar; 2021():. PubMed ID: 33845455
[TBL] [Abstract][Full Text] [Related]
39. Effects of sex steroids on women's health: implications for practitioners.
Derman RJ
Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
[TBL] [Abstract][Full Text] [Related]
40. Ectopic bioactive luteinizing hormone secretion by a pancreatic endocrine tumor, manifested as luteinized granulosa-thecal cell tumor of the ovaries.
Piaditis G; Angellou A; Kontogeorgos G; Mazarakis N; Kounadi T; Kaltsas G; Vamvakidis K; Lloyd RV; Horvath E; Kovacs K
J Clin Endocrinol Metab; 2005 Apr; 90(4):2097-103. PubMed ID: 15687346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
